Marksans Pharma Limited (NSE:MARKSANS)

Marksans Pharma Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Marksans Pharma stock has a consensus rating of "Strong Buy" and an average price target of ₹266.00. The average 1-year stock price forecast is 13.92% higher than the current stock price, while the lowest is ₹210.00 (-10.06%) and the highest is ₹298.00 (+27.62%).

Price Target: ₹266.00 (+13.92%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	₹210.00	₹266.00	₹290.00	₹298.00
Change	-10.06%	+13.92%	+24.20%	+27.62%

Analyst Ratings

The average analyst rating for Marksans Pharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	3	3	3
Buy	1	1	1	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	3	3	3

Financial Forecast

Revenue This Year

34.90B

Increased by 18.28%

from 29.51B

Revenue Next Year

39.31B

Increased by 12.63%

from 34.90B

EPS This Year

11.85

Increased by 28.52%

from 9.22

EPS Next Year

13.50

Increased by 13.92%

from 11.85

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027
Revenue	14.91B	18.52B	21.77B	26.23B	29.51B	34.90B
Revenue Growth	8.33%	24.24%	17.56%	20.46%	12.51%	18.28%
Gross Profit	7.61B	9.12B	11.03B	14.25B	16.74B	19.89B
Gross Margin	51.06%	49.24%	50.67%	54.32%	56.72%	57.00%
Operating Income	2.14B	2.88B	3.84B	4.45B	5.02B	7.39B
Net Income	1.87B	2.66B	3.14B	3.81B	4.18B	5.38B
EPS	-	-	-	-	9.22	11.85
EPS Growth	-	-	-	-	9.76%	28.52%
Forward PE	5.39	5.39	5.39	5.39	5.39	19.70
Dividend / Share	0.25	0.50	0.60	0.80	0.90	2.60
Dividend Growth	-	100.00%	20.00%	33.33%	12.50%	188.89%
Free Cash Flow	-227.75M	661.16M	-510.23M	-725.40M	703.47M	2.89B
No. Analysts	-	-	-	-	-	2

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.

Revenue Forecast

Revenue	2027	2028	2029
High	35.4B
Avg	34.9B
Low	34.4B

Revenue Growth

Revenue Growth	2027	2028	2029
High	19.8%
Avg	18.3%
Low	16.7%

EPS Forecast

EPS	2027	2028	2029
High	-
Avg	11.85
Low	-

EPS Growth

EPS Growth	2027	2028	2029
High	-
Avg	28.5%
Low	-

Data Source: S&P Global Market Intelligence

Price targets, consensus ratings and financial forecasts are provided by S&P Global Market Intelligence. Price targets and consensus ratings update every hour to every three days.

Data Sources Report a data error